Trials / Conditions / Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastroesophageal Junction (GEJ) Adenocarcinoma

7 registered clinical trials studyying Gastroesophageal Junction (GEJ) Adenocarcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808	BigHat Biosciences, Inc.	Phase 1 / Phase 2
Not Yet Recruiting	Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinom NCT07507916	Fudan University	Phase 2
Recruiting	First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors NCT07284186	Plexium, Inc.	Phase 1
Enrolling By Invitation	A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid T NCT07218003	Rondo Therapeutics	Phase 1
Recruiting	An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short NCT07018570	National Cancer Center Hospital East	Phase 2
Unknown	The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors NCT05964543	QureBio Ltd.	Phase 1 / Phase 2
Recruiting	A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastro NCT05365581	Astellas Pharma Global Development, Inc.	Phase 1